Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary ...

The firm is developing the PHOX2B-targeted cell therapy, which has shown promise in preclinical xenograft models, with CHOP researchers.

A new platform comprehensively profiles CAR T-cells during manufacturing, revealing phenotypic shifts. This allows for ...

In modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets.

The cure to cancer may not be hidden in some drug or chemical but within our own body. A team of Chinese researchers recently ...

Analysts at Truist Securities called J&J’s CAR-T readout “compelling,” noting that the efficacy figures could position the ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...